NCT01093963View on ClinicalTrials.gov

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

PHASE3TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Bipolar Depression
Interventions
DRUG

Lisdexamfetamine

oral; 20-70mg/day

DRUG

Placebo

oral; 20-70mg/day

Trial Locations (1)

45040

Lindner Center of HOP, Mason

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

collaborator

University of Cincinnati

OTHER

lead

Lindner Center of HOPE

OTHER